Genentech at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Genentech brings 3 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 125. The Roche Group company's posters look at its oral SERD giredestrant: how tumors respond and resist, thymidine kinase activity in combinations and the societal impact of adjuvant use in HR-positive disease.

OrganizationSABCS 2026 Attendance
Genentech
South San Francisco, CA
Pharma
Roche Group biotechnology company whose breast cancer medicines include HER2-targeted antibodies and treatments for hormone receptor-positive disease.
Booth
Exhibiting at Booth 125
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Poster
Thu Dec 10
12:30–2pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Genentech

Tell us what you sell and we’ll find the people at Genentech most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction